Called ExPlas (exercised plasma), the clinical trial involves taking blood plasma from young and healthy adults who exercise on a regular basis and injecting it into people aged between 50 and 75 in the early stages of Alzheimer's disease.
We know that exercise releases all these hormones which show up in the blood, says Christiane Wrann, an assistant professor of medicine at Harvard Medical.
[
add
]
[
|
|
...
]